Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxysterol-binding protein-related protein 5 (OSBPL5) is a member of the oxysterol-binding protein family, functioning primarily as a lipid transporter at membrane contact sites. It mediates counterexchange of phosphatidylinositol 4-phosphate and phosphatidylserine between the endoplasmic reticulum and the plasma membrane, contributing to cholesterol trafficking in concert with NPC1. OSBPL5 also modulates cell signaling pathways such as mTORC1, influencing cell proliferation and migration, and its dysregulation is linked to cancer metastasis and poor prognosis.
Drugs targeting OSBPL5 might affect lipid transfer and membrane homeostasis, mTOR signaling, and ER-mitochondria communication, but no approved drugs are known to target OSBPL5 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxysterol-binding protein-related protein 5 (OSBPL5).